Furthermore, this study demonstrates that TPGS-FA/NC suppresses hepatoma cell proliferation and hepatic CSCs, as well as the AQP3/STAT3/CD133 axis and Nek2 expression in offering possible multiple mechanisms for its antitumor activity. This evidence concerns the gene NEK2 and hepatocellular carcinoma.